Abstract | BACKGROUND: MATERIAL/METHODS: Eighty pediatric patients, aged between 2 and 6 years, with a history of recurrent external auditory eczema, were enrolled in this study. Congenital immune deficiencies, treatment with corticosteroids, immunostimulant or immunosuppressive agents in the past 6 months, and bronchopulmonary disease were considered as exclusion criteria. The patients were randomized to receive topical suspension of bacterial antigens (Lantigen B) (Group A) or placebo (physiological solution) (Group B). The efficacy parameters were evaluated before, at the end of, and one year after the beginning of the therapy. All the children underwent clinical examinations, blood test, skin prick tests (SPT), and clinical evaluation using the clinical score proposed by Rajka and Langeland, considering the intensity, extent, and course of lesions. RESULTS: In Group A, using the statistical Wilcoxon test, we saw an improvement in the clinical items measured. It is important to consider that the patients were allowed to receive concomitant medications to treat acute episodes, which may have partially contributed to the positive results obtained. CONCLUSIONS:
|
Authors | Renzo Mora, Luisa Bellussi, Francesco Maria Passali, Barbara Crippa, Francesco Mora, Maria Paola Cordone, Marco Barbieri |
Journal | Medical science monitor : international medical journal of experimental and clinical research
(Med Sci Monit)
Vol. 10
Issue 9
Pg. PI99-PI103
(Sep 2004)
ISSN: 1234-1010 [Print] United States |
PMID | 15328495
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antigens, Bacterial
- Placebos
|
Topics |
- Administration, Topical
- Antigens, Bacterial
(administration & dosage, immunology, therapeutic use)
- Child
- Child, Preschool
- Eczema
(drug therapy, immunology, pathology)
- Humans
- Placebos
- Recurrence
|